AKT1 and Alzheimer disease: This hyperactivation of Akt builds resistance against IGF-1 and insulin in AD neurons utilizing the c-Jun N-terminal kinase (JNK)–tumor necrosis factor-α (TNFα) pathway [152,153,154].